The prospect of hemoglobin-based blood substitutes: Still a long stony road to go.
Bone
Hans-Georg
HG
Westphal
Martin
M
D000818:Animals; D001241:Aspirin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D001802:Blood Substitutes / Q000494:pharmacology / Q000627:therapeutic use*; D006419:Heme Oxygenase (Decyclizing) / Q000187:drug effects* / Q000378:metabolism; D051547:Heme Oxygenase-1; D006427:Hemin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D006454:Hemoglobins / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008565:Membrane Proteins; D051381:Rats; D012771:Shock, Hemorrhagic / Q000188:drug therapy*
D001802:Blood Substitutes; D006454:Hemoglobins; D008565:Membrane Proteins; C402601:hemoglobin glutamer-200; D006427:Hemin; C496541:HMOX1 protein, human; D006419:Heme Oxygenase (Decyclizing); D051547:Heme Oxygenase-1; C083478:diaspirin-cross-linked hemoglobin; D001241:Aspirin